Possible Significance of Advanced Glycation End Products in Serum in Find-Stage Renal Disease and in Late Complications of Diabetes)

Clinical Chemistry and Laboratory Medicine

Volumn 34, Issue 4, 1996, Pages 355-362

  Dolhofer Bliesener, Roswitha ^a   Lechner, Brigitte ^a   Gerbitz, Klaus D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLYCATION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; UREMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CREATININE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; UREMIA;

EID: 0029916595     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1996.34.4.355     Document Type: Article

References (32)

1. Wieland OH. Protein modification by nonenzymatic glucosylation: possible role in the development of diabetic complications. Mol Cell Endocrinol 1983; 29: 125-131.
2. Ledl F, Schleicher E. Die Maillard-Reaktion in Lebensmitteln und im menschlichen Körper-neue Ergebnisse zur Chemie, Biochemie und Medizin. Angew Chemie 1990; 102: 597-626.
3. Eble AS, Thorpe SR, Baynes JW. Nonenzymatic glycosylation and glucose-dependent cross-linking of proteins. J Biol Chem 1983; 258: 9406-9412.
4. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 1985; 34: 938-941.
5. Kristal BS, Byung PY. An emerging hypothesis: synergistic induction of aging by free radicals and Maillard reactions. J Gerontol 1992; 47:B:107-B:114.
6. Bucala R, Tracey K, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endotheliumdependent vasodilation in experimental diabetes. J CHn Invest 1991; 87: 432-438.
7. Vlassara H, Brownlee M, Manogue KR, Dinarello C, Pasagian A. Cachectin/TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science 1988; 240: 1546-8.
8. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation endproducts is mediated via platelet-derived growth factor. Proc Natl Acad Sei USA 1992; 89: 2873-7.
9. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151.
10. Hayase F, Nagaraj RH, Miyata S, Njoroge FG, Monnier VM. Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J Biol Chem 1989; 263: 3758-3764.
11. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 1989; 264: 21597-21602.
12. Knecht KJ, Feather MS, Baynes JW. Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: evidence for intermediate stages of the Maillard reaction in vivo. Arch Biochem Biophys 1992; 294: 130-137.
13. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-842.
14. Odetti P, Fogarty J, Sell DR, Monnier VM. Chromatographie quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992; 41: 153-159.
15. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufmann AM, Korbet SM, et al. Reactive glycosylation end products in diabetic uraemia and treatment of renal failure. i 1994; 343: 1519-1522.
16. Dolhofer-Biiesener R, Lechner B, Deppisch R, Ritz E, Gerbitz KD. Immunological determination of advanced glycosylation end-products in human blood and urine. Nephrol Dial Transplant 1995; 10: 657-664.
17. Monnier VM, Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981; 211: 491-493.
18. Chio KS, Tappel AL. Synthesis and characterization of the fluorescent products derived from malondialdehyde and amino acids. Biochemistry 1969; 8: 2827-2832.
19. Wickens DG, Norden AG, Lunec J, Dormandy TL. Fluorescence changes in human gamma-globulin induced by free-radical activity. Biochim Biophys Acta 1983; 742: 607-616.
20. Le Guen CA, Jones AF, Barnett AH, Lunec J. Role of reactive oxygen species in the generation of fluorescence by glycation. Ann Clin Biochem 1992; 29: 184-189.
21. Nakayama H, Taneda S, Kuwajima S, Aoki S, Kuroda Y, Misawa K, et al. Production and characterization of antibodies to advanced glycation products on proteins. Biochem Biophys Res Commun 1989; 162: 740-745.
22. Dolhofer-Bliesener R, Lechner B, Gerbitz KD. Impaired immunoglobulin G Fc fragment function in diabetics is caused by a mechanism different from glycation. Eur J Clin Chem Clin Biochem 1994; 32: 329-336.
23. Sachs L. Angewandte Statistik, Berlin: Springer Verlag, 1974. 24.
24. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 1992; 267: 5133-8.
25. Korbet S, Makita Z, Firanek CA, Vlassara H. Advanced glycosylation end products in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1993; 22: 588-591.
26. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994; 46: 216-222.
27. Taneda S, Monnier VM. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 1994; 40: 1766-1773.
28. Sell DR, Monnier VM. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990; 85: 380-384.
29. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993; 91: 2470-8.
30. Beisswenger PJ, Moore LL, Brinck-Johnson T, Curphey TJ. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 1993; 92: 212-217.
31. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986; 314: 403-408.
32. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sei USA 1994; 91: 11704-8.